Market Overview

Cholesterol Testing Devices - Global Markets to 2022: Abaxis, Abbott, ACON Laboratories, Akers Biosciences, and F. Hoffmann-La Roche Leads the Competition -


The "Global
Cholesterol Testing Devices Market 2018-2022"
report has been
added to's offering.

The Global Cholesterol Testing Devices Market to grow at a CAGR of 6.98%
during the period 2018-2022.

The report has been prepared based on an in-depth market analysis with
inputs from industry experts. The report covers the market landscape and
its growth prospects over the coming years. The report also includes a
discussion of the key vendors operating in this market.

One trend affecting this market is the launch of innovative products.
Vendors in the market are offering products with improved features and
manufacturing standards to create their mark in the market.

According to the report, one driver influencing this market is the high
incidence of CVDs. The increasing incidences of cardiovascular diseases
increases the adoption of cholesterol testing devices for monitoring the
level of cholesterol.

Further, the report states that one challenge affecting this market is
the product recalls. Product recalls affect the company's revenue as
well as the long-term prospects by hampering consumer confidence and the
company's brand image.

Market Trends

  • Launch of Innovative Products
  • Increased Online Presence of Vendors
  • Increased M&A

Key Vendors

  • Abaxis
  • Abbott
  • ACON Laboratories
  • Akers Biosciences
  • F. Hoffmann-La Roche

Key Topics Covered

1. Executive Summary

2. Scope of the Report

3. Research Methodology

4. Market Landscape

5. Market Sizing

6. Five Forces Analysis

7. Customer Landscape

8. Market Segmentation by End-User

9. Regional Landscape

10. Decision Framework

11. Drivers and Challenges

12. Market Trends

13. Vendor Landscape

14. Vendor Analysis

For more information about this report visit

View Comments and Join the Discussion!